![Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010) Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010)](https://eje.bioscientifica.com/view/journals/eje/163/5/images/large/709fig1.jpeg)
Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010)
![Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases](https://www.frontiersin.org/files/Articles/416881/fendo-09-00625-HTML/image_m/fendo-09-00625-g001.jpg)
Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperpro
![Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.ijir.3901476/MediaObjects/41443_2006_Article_BF3901476_Fig1_HTML.gif)